ArticleCancer biology & therapy2020

Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation.

Sang Hoon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.